Press Release

Merck Today Announced the Acquisition of AmpTec
Merck acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics. Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain